Product Information

DOLISHALE 90-20 MCG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $1.0692 per EA under NDC 50742065928. Its NADAC has been published 286 times since Jun 2, 2021.

FDA first approved this application on Oct 22, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOLISHALE 90-20 MCG TABLET

Levonorgestrel and Ethinyl Estradiol
$1.0692per EA

Strength

20; 90 ug/1; ug/1

NDC

50742065928

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091692

FDA Approved

10/22/2020

TE Code

AB

On Market Since

1/3/2021

Pharmacological Classes

Estrogen Receptor Agonists
Estrogen
Inhibit Ovum Fertilization
Progesterone Congeners
Progesterone Congeners
Progestin
Progestin-containing Intrauterine System

Price Statistics

The NADAC for DOLISHALE 90-20 MCG TABLET has been published 286 times since Jun 2, 2021, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0692 per EA
All-time high$1.4130 (Nov 16, 2022)
All-time low$0.7929 (Nov 20, 2024)
52-week high$1.2766
52-week low$1.0692
Median price$1.2175
Average price$1.1764
Largest weekly change-28.9% (Nov 20, 2024)
Weeks tracked286
Tracking sinceJun 2, 2021

Price History

1W

-1.6%

1M

-5.9%

3M

-7.1%

6M

-13.9%

1Y

-14.2%

3Y

+3.7%

5Y

-17.8%

All

-11.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOLISHALE 90-20 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DOLISHALE 90-20 MCG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $1.0692 per EA (NDC 50742065928), effective Nov 18, 2026.

How has the price of DOLISHALE 90-20 MCG TABLET changed over time?

Over the history we have for it, the NADAC for DOLISHALE 90-20 MCG TABLET has declined 11.7%. It has been tracked across 286 weekly CMS publications since Jun 2, 2021.

What are the highest and lowest recorded NADAC prices for DOLISHALE 90-20 MCG TABLET?

Since Jun 2, 2021, the NADAC for DOLISHALE 90-20 MCG TABLET has ranged from a low of $0.7929 (Nov 20, 2024) to a high of $1.4130 (Nov 16, 2022), with a median of $1.2175 per EA.

Are there cheaper alternatives to DOLISHALE 90-20 MCG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOLISHALE 90-20 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DOLISHALE 90-20 MCG TABLET?

DOLISHALE 90-20 MCG TABLET (NDC 50742065928) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.